TE
Tema ETFs Portfolio holdings
AUM
$377M
This Quarter Return
-1.1%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$241M
AUM Growth
–
Cap. Flow
+$241M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
27.78%
Holding
148
New
148
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Rockwell Automation
ROK
|
$9.12M |
| 2 |
Applied Industrial Technologies
AIT
|
$8.13M |
| 3 |
Primoris Services
PRIM
|
$7.13M |
| 4 |
Clean Harbors
CLH
|
$6.6M |
| 5 |
Timken Company
TKR
|
$6.22M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Industrials | 46.25% |
| 2 | Healthcare | 42.59% |
| 3 | Technology | 3.29% |
| 4 | Materials | 2.86% |
| 5 | Financials | 2.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Genmab
GMAB
$16.7B
| $1.23M | 0.51% |
+58,935
| New | +$1.23M |
|
52
GE Aerospace
GE
$293B
| $1.2M | 0.5% |
+7,221
| New | +$1.2M |
|
53
Structure Therapeutics
GPCR
$1.14B
| $1.2M | 0.5% |
+44,343
| New | +$1.2M |
|
54
Visa
V
$681B
| $1.16M | 0.48% |
+3,659
| New | +$1.16M |
|
55
Arrowhead Research
ARWR
$3.84B
| $1.16M | 0.48% |
+61,503
| New | +$1.16M |
|
|
ONC
56
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.5B
| $1.15M | 0.48% |
+6,249
| New | +$1.15M |
|
57
Rocket Pharmaceuticals
RCKT
$358M
| $1.14M | 0.47% |
+90,985
| New | +$1.14M |
|
58
Merck
MRK
$210B
| $1.13M | 0.47% |
+11,342
| New | +$1.13M |
|
59
Madrigal Pharmaceuticals
MDGL
$9.7B
| $1.12M | 0.46% |
+3,620
| New | +$1.12M |
|
|
SWTX
60
DELISTED
SpringWorks Therapeutics
SWTX
| $1.11M | 0.46% |
+30,811
| New | +$1.11M |
|
61
Intercontinental Exchange
ICE
$100B
| $1.11M | 0.46% |
+7,428
| New | +$1.11M |
|
62
Guardant Health
GH
$8.11B
| $1.1M | 0.46% |
+36,120
| New | +$1.1M |
|
63
Mineralys Therapeutics
MLYS
$1.94B
| $1.1M | 0.46% |
+89,529
| New | +$1.1M |
|
64
Day One Biopharmaceuticals
DAWN
$766M
| $1.09M | 0.45% |
+85,761
| New | +$1.09M |
|
65
West Pharmaceutical
WST
$17.9B
| $1.04M | 0.43% |
+3,180
| New | +$1.04M |
|
66
Fair Isaac
FICO
$36.1B
| $1.04M | 0.43% |
+521
| New | +$1.04M |
|
67
S&P Global
SPGI
$165B
| $950K | 0.39% |
+1,907
| New | +$950K |
|
68
Nuvalent
NUVL
$5.74B
| $909K | 0.38% |
+11,617
| New | +$909K |
|
69
Akero Therapeutics
AKRO
$3.65B
| $894K | 0.37% |
+32,150
| New | +$894K |
|
70
Agios Pharmaceuticals
AGIO
$2.36B
| $846K | 0.35% |
+25,735
| New | +$846K |
|
71
Exact Sciences
EXAS
$9.33B
| $843K | 0.35% |
+15,008
| New | +$843K |
|
72
Viking Therapeutics
VKTX
$3.02B
| $813K | 0.34% |
+20,215
| New | +$813K |
|
73
Sherwin-Williams
SHW
$90.5B
| $800K | 0.33% |
+2,353
| New | +$800K |
|
|
NARI
74
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $755K | 0.31% |
+14,790
| New | +$755K |
|
75
Celldex Therapeutics
CLDX
$1.57B
| $745K | 0.31% |
+29,480
| New | +$745K |
|